Popular Stories

Novan Inc. Tag

  • All
  • Biotechnology
  • Cannabis
  • Education
  • Energy
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Can Novan Nitric Oxide Based Approach pay off in the long run?

Novan, Inc. (NASDAQ: NOVN), a clinical–stage Biotechnology Company leveraging its expertise in nitric oxide-based therapies, has entered into a Master Services Agreement (MSA) with Catalent for supporting the development and chemistry, manufacturing and control (CMC) activities for berdazimer sodium, to be made into an intranasal...

A paradigm shift in the ACNE treatment industry?

Acne is one of the most common skin disorders in the U.S affecting over 50 million people annually. An estimated 85% of young adults aged between 12-25 years suffer from it according to the Global Burden of Disease (GDB) study. The rise in androgen levels during puberty,...

WordPress Video Lightbox Plugin